MENLO PARK, Calif. (AP) _ Corcept Therapeutics Inc. (CORT) on Monday reported first-quarter net income of $4.4 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Menlo Park, California-based company said it had profit of 4 cents.
The drug developer posted revenue of $27.6 million in the period.
Corcept expects full-year revenue in the range of $125 million to $135 million.
Corcept shares have climbed 33 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $9.67, more than doubling in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CORT at https://www.zacks.com/ap/CORT
Keywords: Corcept Therapeutics, Earnings Report